KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Liabilities and Shareholders Equity: 2009-2024

Historic Liabilities and Shareholders Equity for Colgate Palmolive (CL) over the last 16 years, with Dec 2024 value amounting to $16.0 billion.

  • Colgate Palmolive's Liabilities and Shareholders Equity rose 4.41% to $17.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $67.7 billion, marking a year-over-year increase of 2.20%. This contributed to the annual value of $16.0 billion for FY2024, which is 2.12% down from last year.
  • As of FY2024, Colgate Palmolive's Liabilities and Shareholders Equity stood at $16.0 billion, which was down 2.12% from $16.4 billion recorded in FY2023.
  • In the past 5 years, Colgate Palmolive's Liabilities and Shareholders Equity registered a high of $16.4 billion during FY2023, and its lowest value of $15.0 billion during FY2021.
  • Its 3-year average for Liabilities and Shareholders Equity is $16.1 billion, with a median of $16.0 billion in 2024.
  • In the last 5 years, Colgate Palmolive's Liabilities and Shareholders Equity rose by 5.89% in 2020 and then fell by 5.53% in 2021.
  • Yearly analysis of 5 years shows Colgate Palmolive's Liabilities and Shareholders Equity stood at $15.9 billion in 2020, then declined by 5.53% to $15.0 billion in 2021, then climbed by 4.59% to $15.7 billion in 2022, then grew by 4.21% to $16.4 billion in 2023, then fell by 2.12% to $16.0 billion in 2024.